Latest news

16 Apr 2019 News
Oncology conferences and event highlights: April–June 2019
16 Apr 2019 Lung
US FDA expands the approval of Keytruda® in Stage III NSCLC
15 Apr 2019 Lung
Maintenance immunotherapy fails to improve survival in extensive-stage SCLC
15 Apr 2019 Colorectal
Organoid study sheds light on how colorectal cancer cells may avoid immunotherapy

Video

View all videos

13 Feb 2019 Lung
Tumor clonality and resistance mechanisms in EGFR mutation-positive NSCLC: implications for therapeutic sequencing

Video

View all videos

Features

Stay up to date

Upcoming event

Gastrointestinal Cancers Symposium

January 17, 2019 – January 19, 2019

CA, USA

View all

Upcoming event

International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer

February 9, 2019 – February 11, 2019

Kyoto, Japan

View all

Tweets

Oncology Central @OncologyCentral·

Results from the DART clinical trial indicate that ipilimumab plus nivolumab may be beneficial to patients with high-grade #neuroendocrinecarcinoma. Click the image below for the full news story: https://t.co/2C7epMD2Aq

View all

Jobs

Connecting talent with opportunity. View our featured jobs

View all

Our mission statement

At Oncology Central we are dedicated to advancing oncology by publishing trusted, engaging and insightful resources for the global oncology community.

Learn more

Oncology conferences and event highlights: April–June 2019

US FDA expands the approval of Keytruda® in Stage III NSCLC

Maintenance immunotherapy fails to improve survival in extensive-stage SCLC

Organoid study sheds light on how colorectal cancer cells may avoid immunotherapy

Spotlight survey on organoids on oncology

Pembrolizumab for small-cell lung cancer: an interview with Hyun Cheol Chung

Pharma, President, Patients: the cancer cost conundrum

Lung squamous cell carcinoma: key molecular player discovered

Colorectal cancer screening age to be lowered to 50 in England

Exploring the Thyroid Imaging Reporting and Data System (TI-RADS): an interview with Franklin Tessler

Q&A follow up: A closer look at physical activity and cancer prevention

A closer look at: physical activity and cancer prevention

Induction of receptor tyrosine kinase signaling by sera isolated from patients with lung adenocarcinoma

Video

Tumor clonality and resistance mechanisms in EGFR mutation-positive NSCLC: implications for therapeutic sequencing

Video

Login

Latest news

Oncology conferences and event highlights: April–June 2019

US FDA expands the approval of Keytruda® in Stage III NSCLC

Maintenance immunotherapy fails to improve survival in extensive-stage SCLC

Organoid study sheds light on how colorectal cancer cells may avoid immunotherapy

Featured articles

Spotlight survey on organoids on oncology

Pembrolizumab for small-cell lung cancer: an interview with Hyun Cheol Chung

Pharma, President, Patients: the cancer cost conundrum

Lung squamous cell carcinoma: key molecular player discovered

Colorectal cancer screening age to be lowered to 50 in England

Exploring the Thyroid Imaging Reporting and Data System (TI-RADS): an interview with Franklin Tessler

Q&A follow up: A closer look at physical activity and cancer prevention

A closer look at: physical activity and cancer prevention

Induction of receptor tyrosine kinase signaling by sera isolated from patients with lung adenocarcinoma

Video

Tumor clonality and resistance mechanisms in EGFR mutation-positive NSCLC: implications for therapeutic sequencing

Video

HTX-019 2-min injection shows promise as an alternative method of administration to prevent CINV

Unraveling the tumor biology of pancreatic cancer with Harpreet Wasan

Tumor clonality and resistance mechanisms in EGFR mutation-positive NSCLC: implications for therapeutic sequencing

Emerging treatment options for pancreatic cancer with Thomas Seufferlein

Tamoxifen, SERMs and sustainable medicine

Seven challenges in immuno-oncology

Features

Interviews

Spotlights

Journal articles

Stay up to date

Oncology Central Newsletter